Delivery Order SPE2DB20D1100-SPE2DB25FA2J7

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NURTEC ODT 75 MG tablets to the Defense Logistics Agency (DLA), a defense agency. The $56,261.95 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a total ceiling value of $10,390.71. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $25,536.59 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 14, 2024 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,648.21 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of April 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $13,471.95 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with an ultimate completion date of August 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,138.28 Firm Fixed Price Delivery Order is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract has an ultimate completion date of April 21, 2023. AmerisourceBergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of NURTEC ODT 75 MG TABLET 8S. The $6,630.99 firm fixed price delivery order contract has an ultimate completion date of January 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA). The $10,541.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,018.82 firm fixed-price delivery order is for NURTEC ODT 75 MG TABLET 8S, with a completion date of November 27, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $37,096.53, was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor to the U.S. government. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA2J7
    Delivery Order

This contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,071.73 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, and does not have a set-aside designation.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 4/25/25, 9:48 AM